ABCC2 and epilepsy: The results of this study indicate that the ABCC2 1249G>A (rs2273697) and ABCC2 −24C>T (rs717620) polymorphisms affect the plasma concentrations and treatment efficacy of LCM in pediatric patients with epilepsy, leading to drug resistance.